Impax Asset Management Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
WA
Impax Asset Management Group's MDT Position: Q1 2022 in Review
Impax Asset Management Group sold out of Medtronic (MDT) in Q1 2022, closing a stake of 331,875 shares — an estimated $34.3M sold.
Impax Asset Management Group first reported a position in MDT in Q3 2018 and held it in 14 quarters. The position peaked at $34.3M in Q4 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.
- Impax Asset Management Group reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
- Impax Asset Management Group sold 331,875 Medtronic shares in Q1 2022, an estimated $34.3M.
- Impax Asset Management Group first reported a position in Medtronic in Q3 2018 and held it in 14 quarters.
- Impax Asset Management Group's Medtronic position peaked at $34.3M in Q4 2021.
- 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.
Based on Impax Asset Management Group's 13F filing for Q1 2022, filed 16 May 2022.